Prosecution Insights
Last updated: October 01, 2026
Application No. 19/216,015

CAREGIVER ASSISTANCE SYSTEM

Non-Final OA §DP
Filed
May 22, 2025
Priority
Jun 28, 2019 — provisional 62/868,387 +5 more
Examiner
REYES, REGINALD R
Art Unit
Tech Center
Assignee
Stryker Corporation
OA Round
1 (Non-Final)
41%
Grant Probability
Moderate
1-2
OA Rounds
2y 12m
Est. Remaining
73%
With Interview

Examiner Intelligence

Grants 41% of resolved cases
41%
Career Allowance Rate
253 granted / 617 resolved
-19.0% vs TC avg
Strong +32% interview lift
Without
With
+31.9%
Interview Lift
resolved cases with interview
Typical timeline
4y 4m
Avg Prosecution
39 currently pending
Career history
657
Total Applications
across all art units

Statute-Specific Performance

§101
41.5%
+1.5% vs TC avg
§103
33.2%
-6.8% vs TC avg
§102
7.4%
-32.6% vs TC avg
§112
11.2%
-28.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 617 resolved cases

Office Action

§DP
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory obviousness-type double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); and In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on a nonstatutory double patenting ground provided the conflicting application or patent either is shown to be commonly owned with this application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. Effective January 1, 1994, a registered attorney or agent of record may sign a terminal disclaimer. A terminal disclaimer signed by the assignee must fully comply with 37 CFR 3.73(b). Claims 1-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-20 of U.S. Application No. 19/216011, 1-20 of U.S. Application No. 18/780073, 1-20 of U.S. Application No. 17854053, claims 1-20 of U.S. Application No. 16/832767 and claims 1-20 of U.S. Application 16/716725 and U.S. Application 17622593. Although the claims at issue are not identical, they are not patentably distinct from each other because they use similar language to claim common subject matter. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to REGINALD R REYES whose telephone number is (571)270-5212. The examiner can normally be reached 8:00-4:30 M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Shahid R. Merchant can be reached at (571) 270-1360. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. REGINALD R. REYES Primary Examiner Art Unit 3684 /REGINALD R REYES/Primary Examiner, Art Unit 3684
Read full office action

Prosecution Timeline

May 22, 2025
Application Filed
Sep 22, 2026
Non-Final Rejection mailed — §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12725699
Home Dialysis Machine Network Including Walk-Up Service Centers
2y 4m to grant Granted Sep 01, 2026
Patent 12712086
SYSTEMS AND METHODS FOR CONTAGIOUS ILLNESS SURVEILLANCE AND OUTBREAK DETECTION
1y 10m to grant Granted Aug 18, 2026
Patent 12706219
SYSTEMS AND METHODS FOR SCAN PREPARATION
2y 3m to grant Granted Aug 11, 2026
Patent 12706217
AI IMAGE DIAGNOSIS DEVICE AND DENTAL OCT IMAGE DIAGNOSIS DEVICE
2y 0m to grant Granted Aug 11, 2026
Patent 12700495
TRACKING AND QUALITY ASSURANCE OF PATHOLOGY, RADIOLOGY AND OTHER MEDICAL OR SURGICAL PROCEDURES
2y 0m to grant Granted Aug 04, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
41%
Grant Probability
73%
With Interview (+31.9%)
4y 4m (~2y 12m remaining)
Median Time to Grant
Low
PTA Risk
Based on 617 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month